Kamyar Kalantar-Zadeh
Overview
Explore the profile of Kamyar Kalantar-Zadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
1044
Citations
28548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leduc C, Tomisawa N, Ronco C, Kalantar-Zadeh K
Curr Opin Nephrol Hypertens
. 2025 Feb;
PMID: 39963825
Purpose Of Review: Online hemodiafiltration (OL-HDF) is a type of outpatient intermittent dialysis therapy using purified online dialysis fluid sourced from the city water supply. OL-HDF has been widely practiced...
2.
Cohen-Hagai K, Saban M, Antebi A, Benchetrit S, Nacasch N, Erez D, et al.
Kidney360
. 2025 Feb;
PMID: 39928423
Background: Patient-reported outcomes, such as satisfaction with care, are essential for assessing and improving healthcare quality, especially in populations with chronic conditions like hemodialysis patients. In diverse societies, understanding how...
3.
Takahashi R, Bui T, Elali I, Tran D, Sumida K, Thomas F, et al.
Am J Nephrol
. 2025 Jan;
:1-11.
PMID: 39870055
Introduction: Niacin is a non-statin lipid-lowering therapy that has been shown to lower triglycerides and improve other risk factors for renal outcomes. Despite these favorable data, the effect of niacin...
4.
Kalantar-Zadeh K, Raff E, Chong C, Yang J, Le T, Barba L, et al.
Clin J Am Soc Nephrol
. 2024 Dec;
20(3):455-457.
PMID: 39656515
No abstract available.
5.
Rhee C, Gianchandani R, Kerr D, Philis-Tsimikas A, Kovesdy C, Stanton R, et al.
J Diabetes Sci Technol
. 2024 Nov;
19(1):217-245.
PMID: 39611379
This report represents the conclusions of 15 experts in nephrology and endocrinology, based on their knowledge of key studies and evidence in the field, on the role of continuous glucose...
6.
Narasaki Y, Rhee C, Kalantar-Zadeh K, Rastegar M
Curr Opin Nephrol Hypertens
. 2024 Nov;
34(1):55-66.
PMID: 39611279
Purpose Of Review: Protein-energy wasting (PEW) is increasingly more prevalent as chronic kidney disease (CKD) progresses to more advanced stages. There is a global recognition of the importance of preventing...
7.
Brown C, Pham P, Shah A, Dukkipati R, Shen J, Elali I, et al.
Curr Opin Nephrol Hypertens
. 2024 Nov;
34(1):41-47.
PMID: 39611278
Purpose Of Review: Chronic kidney disease (CKD) is a widespread health issue, affecting one out of every 10 adults. This prevalence is even higher among vulnerable and underserved populations, including...
8.
Rhee C, Kovesdy C, Unruh M, Crowley S, Geller D, Goldfarb D, et al.
Curr Opin Nephrol Hypertens
. 2024 Nov;
34(1):33-40.
PMID: 39611277
Purpose Of Review: Initiation of hemodialysis treatment with a thrice-weekly prescription is currently the standard of care irrespective of patients' residual kidney function (RKF), comorbidities, and preferences. Recent Findings: Each...
9.
Tantisattamo E, Hanna R, Kalantar-Zadeh K
Curr Opin Nephrol Hypertens
. 2024 Nov;
34(1):1-3.
PMID: 39611276
No abstract available.
10.
Brown C, Pham P, Shah A, Dukkipati R, Shen J, Dai T, et al.
Curr Opin Nephrol Hypertens
. 2024 Nov;
PMID: 39575838
Purpose Of Review: Chronic kidney disease (CKD) is a widespread health issue, affecting one out of every 10 adults. This prevalence is even higher among vulnerable and underserved populations, including...